Axogen, Inc. · NASDAQ:AXGN
Wendell Amy McBride sold 13,353 Axogen, Inc. shares (Form 4)
Traded Aug 11, 2026 · Filed Aug 12, 2026
On Aug 11, 2026, Wendell Amy McBride (Director) sold 13,353 Axogen, Inc. shares at US$48.42 for US$647K under a trading plan, leaving 107,976 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 13,353 shares
- Price
- US$48.42
- Value
- US$647K
- Holding after
- 107,976 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Common Stock | Option exercise | 13,353 | US$14.85 | 121,329 | Direct |
| Aug 11, 2026 | Common Stock | Sale | 13,353 | US$48.42 | 107,976 | Direct |
Source
Related
- Axogen, Inc.
- Wendell Amy McBride
- Axogen, Inc. shareholders
- Form 4 · Wendell Amy McBride · Jun 23, 2026
- Form 4 · Wendell Amy McBride · May 12, 2026
- Schedule 13G · Divisadero Street Capital Management, LP · Oct 2, 2026
- Form 4 · Tyndall Joseph A. · Sep 4, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Aug 14, 2026
- Form 4 · Began Marc A · Aug 12, 2026
- Form 4 · Weiler Kathy Johnson · Aug 11, 2026